Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02146573 · ClinicalTrials.gov registry record · NA

Pediatric Continuity Care Intensivist

A NA study of Critical Illness, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
276
Enrollment target
1
Study location

NCT02146573 is a NA study of Critical Illness that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 276 participants, below the 3,135-participant average among 91 other Critical Illness trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02146573, a NA study of Critical Illness, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
276 participants
Enrollment target
1
Study location

Study Summary

This study will implement and evaluate the effects of a pediatric continuity care intensivist program. This study will determine the impact of an additional pediatric intensive care unit (PICU) intensivist on outcomes at the patient and family level. It will also evaluate the training program to prepare the continuity care intensivist (CCI).

Conditions Studied

Interventions

  • BEHAVIORAL Continuity Care Intensivist Communication Training
  • BEHAVIORAL Continuity Care Intensivist (CCI) Provider Program

Study Locations (1)

Pennsylvania

  • The Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 276 participants
Start Date 2014-05
Est. Completion 2018-12
Phase NA

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT02146573

The ClinicalTrials.gov registry entry for NCT02146573 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,135-participant average among 91 other Critical Illness trials with a reported enrollment target (91% lower). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Continuity Care Intensivist Communication Training is the first listed.

NCT02146573 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02146573 about?

NCT02146573 is a clinical study titled "Pediatric Continuity Care Intensivist". This study will implement and evaluate the effects of a pediatric continuity care intensivist program. This study will determine the impact of an additional pediatric intensive care unit (PICU) intensivist on outcomes at the patient and family level. It will also evaluate the training program to pre...

What is the current status of trial NCT02146573?

This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2014-05. Estimated completion is 2018-12.

What conditions does trial NCT02146573 study?

This clinical trial studies the following conditions: Critical Illness.

What interventions are being tested in trial NCT02146573?

The interventions under investigation include: Continuity Care Intensivist Communication Training (BEHAVIORAL), Continuity Care Intensivist (CCI) Provider Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02146573?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02146573 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.